analysis at the single-cell level is essential for the understanding of cellular responses in heterogeneous cell populations, but it has been difficult to perform because of the strict requirements put on detection methods with regard to selectivity and sensitivity (i.e., owing to the cross-reactivity of probes and limited signal amplification). Here we describe a 1.5-d protocol for enumerating and genotyping mrna molecules in situ while simultaneously obtaining information on protein interactions or post-translational modifications; this is achieved by combining padlock probes with in situ proximity ligation assays (in situ pla). In addition, we provide an example of how to design padlock probes and how to optimize staining conditions for fixed cells and tissue sections. Both padlock probes and in situ pla provide the ability to directly visualize single molecules by standard microscopy in fixed cells or tissue sections, and these methods may thus be valuable for both research and diagnostic purposes.
IntroDuctIon
When observing a population of cells under a microscope, the differences between single cells appear obvious. Whether this variation has consequences at the macroscopic level of tissues and organs is still not fully understood. The study of cell-to-cell variation has now become an important focus of biological and clinical research. The shift from population-based studies to single-cell 'omics' has been boosted by the development of techniques that can decipher the genetic, transcriptional, proteomic and metabolomic content of individual cells. In fact, when addressing cell-to-cell variation, single-cell analyses are necessary in order to study and characterize the intrinsic heterogeneity of cell populations, which are masked in bulk measurements [1] [2] [3] [4] . Single-cell analyses carried out in situ enable the identification and discrimination of cells within a microenvironment, thereby identifying subpopulations of cells with a particular expression profile or signaling activity status from the bulk of others in the original environment. This will be increasingly important for studies of cancers, in which the malignant cells evolve from and are shaped by the surrounding nonmalignant cells, and for diseases in which tissues comprise both healthy (or largely unaffected) cells and pathological cells.
Padlock probes and in situ PLA-methods developed in our laboratory 5, 6 ( Fig. 1) -enable the simultaneous genotyping of transcripts, measurement of relative mRNA and protein expression levels, and the detection of protein modifications or protein complex formation; all these can be preformed directly in fixed cells. Padlock probes can be used to study a number of aspects at the mRNA level, from single-nucleotide substitution (e.g., point mutations, single-nucleotide polymorphisms (SNPs) and RNA-edited transcripts) 5 to tissue-specific allele expression and spliced or fused transcript variants. In contrast, in situ PLA can provide information about the signaling cascade activity, e.g., post-translational modifications (PTMs) 7 and interactions between proteins 6 . The combination of these two methods enables studies of the kinetics of gene expression by following a signaling cascade, as shown in a proofof-principle study for the detection of the phosphorylated plateletderived growth factor receptor-β (PDGFR-β) and its downstream target DUSP6 (encoding dual-specificity phosphatase 6) mRNA 8 . Genotyping of cells in parallel with the visualization of protein activity is also made possible through the combination of the two techniques. As the two protocols (in situ PLA and padlocking in situ) should be tested separately before combining them, we also present a compact version of the protocol for in situ mRNA detection, both in cells and in tissues (Box 1).
Overview of the procedure
For in situ detection of individual transcripts, the mRNA of interest is first converted into localized cDNA using a primer containing locked nucleic acid (LNA)-modified bases. The LNA bases serve to immobilize the cDNA molecule to the targeted mRNA, as they protect the RNA from RNase H digestion. The cDNA is then visualized using padlock probes and target-primed rolling-circle amplification (RCA) 5 . Padlock probes are linear oligonucleotides of approximately 70-100 nt in length. The 5′ and 3′ ends contain a sequence that is complementary to the target flanking sequence for a recognition motif for probe-specific visualization. Hybridization of the padlock probes to the target molecule renders the two probe ends hybridized next to each other in a head-to-tail orientation. They may then be covalently joined together by enzymatically
In situ detection of individual mRNA molecules and protein complexes or post-translational modifications using padlock probes combined with the in situ proximity ligation assay catalyzed DNA ligation, resulting in a circular molecule. Ligation will only occur if there is a perfect match between the probe and the target at the ligation junction, and thus mismatched probes remain linear. This property provides the assay with the capacity to genotype single-nucleotide substitutions. Circularized padlock probes can then be amplified using the 3′ end of the cDNA as a primer for DNA replication. This will ensure that the resulting RCA product (RCP) stays linked to the detected RNA molecule (i.e., the RCP will be an extension of the cDNA molecule). After completion of RCA, detection oligonucleotides labeled with fluorophores are hybridized to a complementary sequence present in hundreds of copies in every RCP, which stems from the recognition motif in the padlock probe sequence. Accordingly, each detected target molecule can be visualized as a bright spot via a fluorescence microscope, thereby enabling exact quantification of the detected target molecules and localization of the individual signals 9 . This padlock probe-based method is particularly suitable for the detection and genotyping of point mutations and SNPs because of the high specificity of the DNA ligase at the 3′ or 5′ end of the ligation template. Thus, to discriminate between single-nucleotide variants, the padlock probes are designed to differ at one nucleotide position at the 3′ end, as well as at the recognition motif, as only probes with a perfect match will be ligated into a circular molecule 9 .
In situ PLA was developed to study protein complexes 6 and PTMs 7 in fixed cells and tissues and for the highly specific detection of single proteins 10 . The assay is based on the use of PLA probes, which are antibodies to which oligonucleotides have been conjugated. Once the conjugated antibodies bind to the same target complex, the oligonucleotide parts of the PLA probes are brought into proximity; they can then act as templates for hybridization and subsequent ligation of two circularization oligonucleotides, thus forming a circular DNA molecule. The resulting DNA circle can then be amplified by RCA primed from one of the oligonucleotides on the PLA probe, thereby ensuring that the resulting RCP stays linked to the protein complex. Visualization of in situ PLA signals is achieved by hybridization of fluorescently labeled oligonucleotides to the RCPs. For circumstances with a high concentration of signals, an alteration of the assay that increases the dynamic range can be used 11 . In addition, in situ PLA has also been used to detect proteins on western blots 10 and to detect protein-DNA interactions 12 .
As both padlock probes and in situ PLA use RCA for signal amplification, they can be combined, thereby providing an assay that simultaneously examines the gene expression and protein activity 8 (Fig. 1) . After fixation and permeabilization of the cells, the protocol starts with the padlock probe-specific reaction steps: after first-strand cDNA synthesis, the padlock probe target site is rendered single stranded by RNase H digestion, degrading RNA only within DNA-RNA heteroduplexes. Subsequent to hybridization and ligation of the padlock probes to their specific target, in situ PLA detects the protein complexes or PTMs of interest using antibodies directed against these proteins. The antibodies are either directly conjugated to an oligonucleotide specific to each one of the two antibodies, or they are used as primary antibodies together with secondary, species-specific PLA probes. After binding PLA probes to their target proteins, circularization oligonucleotides are hybridized to the oligonucleotides carried by the PLA probes and thereafter ligated to form a circle. All circular molecules in the sample, stemming from either the mRNA or the detected proteins, are then amplified by RCA. The resulting RCPs stay attached to the initiating PLA probe or cDNA molecule and can be localized and made visible by hybridization of different fluorophore-labeled detection oligonucleotides.
Application of the method SNP detection using padlock probes was first demonstrated for the detection and genotyping of the mitochondrial encephalomyopathy, lactic acidosis and stroke-like episode (MELAS) point mutation in mitochondrial DNA in cell lines and fresh-frozen tissues 9 . Since then, padlock probes have been used for the detection of repetitive genomic sequences 13 and of bacterial and viral infection in cells and tissue 14, 15 . More recently, a padlock probe assay enabling in situ analysis of RNA sequences and sequence variants was developed 5 . This RNA analysis protocol has been adjusted for application to both cytological tumor imprints and formalinfixed paraffin-embedded (FFPE) tissues, enabling single-cell mutation detection for diagnostic molecular pathology (I.G. et al., unpublished data).
In situ PLA has been used to detect proteins, protein interactions and PTMs in fixed cells and tissue sections. The advantage of the method is that it targets endogenously expressed proteins, thus providing a tool for performing studies in clinical samples. The stained cells can be visualized by microscopy or flow cytometry 16 . For highly autofluorescent tissue sections, RCPs can be detected using enzyme-labeled detection probes 17 .
Combining mRNA detection with padlock probes with in situ PLA expands the information that can be derived from individual cells (Fig. 1) . The assays-either used individually or in combination-can be used to identify heterogeneity in cellular responses and to provide information on several levels in a signaling network.
Comparison with other methods
Despite a lower sensitivity compared with other methods for gene expression analysis, the padlock probe assay presents several advantages over these methods. In situ hybridization 18, 19 and fluorescence in situ hybridization (FISH) 20, 21 are widely used to detect mRNA molecules in situ. However, they cannot distinguish between highly similar sequences, rendering them unsuitable for studying cellspecific allelic expression or expression of splice variants. Moreover, hybridization-based methods are typically semiquantitative and do not allow precise digital quantification of the signals. Alternatives to hybridization-based methods are quantitative PCR (qPCR) or RNA sequencing (RNA-seq) on cells isolated by laser-capture microdissection 22, 23 or via fluorescence-activated cell sorting (FACS). These quantitative methods are sensitive and offer higher throughput, but they are expensive, time-consuming and lack the spatial information about the original environment of the isolated cells.
Detection of protein complex formation in situ can be determined by fluorescence resonance energy transfer (FRET) 24, 25 or protein fragment complementation assays 26 . These assays have the advantage that they can be performed in living cells, although they require the targeted protein pair to be expressed as a fusion with fluorescent reporter molecules. However, the detection of endogenous protein interactions or PTMs in fixed tissue sections with antibody-based FRET can be challenging, owing to high autofluorescence caused by the fixative.
Limitations
The overall efficiency of in situ detection of transcripts in cell lines using padlock probes has been estimated to be ~30%, as determined by qPCR 5 . This might prevent the detection and genotyping of transcripts with low expression levels. The efficiency is further negatively affected by an increasing number of LNA-containing primers present during cDNA synthesis, probably as a consequence of the strong binding capacity of LNA bases to each other. Combining padlock probes with in situ PLA reduces the number of detected events by ~50% compared with when they are run as individual assays 8 . When establishing the in situ PLA protocol, it must be taken into consideration that the applied antibodies must be able to detect their target in paraformaldehyde (PFA)-fixed samples.
Experimental design General considerations. We recommend that protocols for both padlock probes and in situ PLA be evaluated separately for each new target combination before they are combined. Only if both in situ PLA and padlock probe detection work separately should the two protocols be combined. However, because of the differences in the protocols, some problems may still arise even though the separate protocols work well. It is important to work in an RNase-free environment. All buffers and reaction mixtures should be prepared from diethyl pyrocarbonate (DEPC)-treated Milli-Q water. During and after hybridization of the fluorescently labeled detection oligonucleotides to the RCPs, the samples should be protected from light in order to avoid bleaching of the fluorophores.
As for most antibody-based techniques, results obtained with in situ PLA are only as good as the antibodies used. Therefore, excellent antibody quality is the most important parameter for this method. When using the combined protocol, it is advised to use antibodies that recognize their targets even after formaldehyde fixation, because ethanol-fixed samples will not yield a good signal for the mRNA detection (see Limitations). Another important parameter is the activity of the enzymes used. Ligases (T4 ligase and Ampligase) and phi29 DNA polymerase should always be kept on ice while setting up the reaction. All enzymes should be kept at − 20 °C until immediately before use. Add the enzyme just before applying the reaction mixture to the sample and avoid letting the complete reaction mixture stand at room temperature (RT; 20-23 °C) for an extended time. Although reduced enzyme activity might not result in a complete abolishment of the signal, the impact on the results can be substantial.
Long incubation times (e.g., during reverse transcription) can result in a substantial reduction of reaction volume. This may impair the reaction, resulting in less padlock probe signal than desired. The use of Secure Seal chambers helps circumvent this problem, although additional washing might be needed to avoid higher autofluorescence background. Detection oligonucleotides for the padlock and the PLA probes should be selected such that they do not cross-react and that the fluorophores used are easily separable in each user's individual fluorescence microscope setup.
General guidelines for designing oligonucleotides. For the in situ padlocking assay, the design of padlock probes and LNA primers for cDNA synthesis is aided by the following guidelines. Oligonucleotides should be tested to ensure that they are specific for the target, e.g., using BLAST (http://blast.ncbi.nlm.nih.gov/). This is especially important for the padlock probes, and we recommend BLASTing only the target sequence before adding the linker sequence in order to ensure that specific ligation is obtainable for your target. Oligonucleotides for in situ PLA and in situ detection of mRNA are ordered from commercial vendors with HPLC purification (sequences detailed in Table 1 ). LNA primers are HPLC purified as well, and the padlock probes should be purified by PAGE.
Padlock probes. The padlock probe target-specific sequence should be complementary to the cDNA sequence. Therefore, start by selecting a target sequence for the padlock probe on the cDNA strand. The target region should preferably be ~40 nt long; this length works well for both GC-poor and GC-rich sequences. When the padlock probe is not directed at a fixed position (e.g., targeting an SNP), select a region that has a good balance of G/C and A/T. The two target-specific parts can be of different lengths, but for simplicity it is a good idea to keep them equal in length when designing several padlock probes. For targeting SNPs or point mutations, the nucleotide position of interest should be placed at the ultimate 3′ end of the probe. This places the position of interest directly adjacent to the nick that is sealed by the ligase, ensuring the highest possible discriminatory power in the ligation reaction. When the target-specific parts of the padlock probe are set, add a linker between these two parts. A general rule for the length of the linker sequence is the complete length of the target-specific parts plus another 10 nt. A probe with a 40-nt-long target sequence will thus have a total length of 90 nt. The linker should contain a sequence corresponding to the sequence of a fluorescently labeled detection oligonucleotide, and if the probe will be used in multiplexed or genotyping reactions this sequence must be unique for each padlock probe. Design the detection oligonucleotide to be between 20 and 25 nt in length, and order them from the vendor with a fluorophore at the 5′ end. Ensure that the detection sequence is not present in the genome of the species that you will study in order to minimize background staining. Before use, the padlock probes should be phosphorylated. Padlock probes can also be ordered with a 5′ phosphate.
LNA primer. The LNA primer is ~25 nt in length and is optimally positioned within a distance of 20 nt from the 5′ end of the padlock probe target site. Optimization experiments have shown a decrease in the number of signals with an increased distance between the primer and the padlock probe target site. A 20-nt distance produced only 30% of the number of signals obtained for a primer at a 7-nt distance. Primers slightly overlapping the padlock probe target site also work well, as long as the overlap does not extend to the primer part containing the LNA-modified bases. If possible, choose a region that has a good balance between the G/C and A/T content. To anchor the cDNA to the mRNA, six or seven bases in the 5′ end of the primer should consist of LNA-modified bases 5 . The LNA-modified bases should be placed in every second nucleotide position. Use tools such as UNAFold (Integrated DNA Technologies) or the open-source software Primer3 (http:// primer3.wi.mit.edu/) to check the secondary structure of your primers. In cases in which the primer contains stems in the secondary structure, avoid putting LNA bases in these positions or, if possible, try to find a more suitable target region for the LNA primer (see Table 1 and Fig. 2 for a design example) .
PLA probes. Protocols to make PLA probes are described elsewhere 27, 28 . Briefly, thiol-or amine-modified oligonucleotides can be covalently conjugated to primary amines on the antibodies using a bifunctional cross-linker, e.g., succinimidyl-4-(N-maleimidom ethyl)cyclohexane-1-carboxylate (SMCC; Pierce) or succinimidyl 6-hydrazinonicotinate acetone hydrazone (SANH; Solulink). Alternatively, conjugation kits that convert antibodies into PLA probes can be used (Olink Biosciences).
Protocol optimization. For padlock probes, there are some alternatives for permeabilization of the cells: cultured cells can be permeabilized with 70% (vol/vol) ice-cold ethanol and tissue sections can be permeabilized with a 2-min incubation at 37 °C with 0.1 M HCl and 2 mg ml − 1 pepsin. This step could be optimized for different tissue types with respect to time and pepsin concentration. For antibodies and PLA probes, the fixation and permeabilization protocols recommended by the vendor should be used, but they must be tested by the users for each new antibody and PLA probe. The concentration should be titrated for each antibody used to obtain optimal conditions.
Controls.
To ensure that unsatisfactory results are not due to sample variation, negative and positive controls should be used during protocol establishment and as part of each experiment to help maintain the quality of the results. A cell line expressing the target mRNA and the desired proteins, in which protein complexes are readily formed, can be used as a positive control. The same cell line can serve as a negative control if the protein or mRNA of interest has been knocked out, knocked down or the complex formation has been impaired. For comparison with positive samples, the same type of sample can be run but without the M-MuLV reverse transcriptase as a negative control for mRNA detection by padlock probes. For further examples of technical controls, see In situ RCA generates long concatamers of DNA, which can be easily distinguished as bright dots of around 1 µm in size using fluorescence microscopy. The signals originating from padlock probe reactions and those originating from PLA reactions will appear alike, although they will be visible at different wavelengths depending on the fluorophore used. Because of high local concentrations of fluorophores within the coiled DNA molecule, the RCPs are characterized by a high signal-to-background ratio, which makes it possible to quantify the number of signals using appropriate image analysis software. RCPs can be distinguished from autofluorescence because they exclusively appear as bright distinct spots in the range of wavelengths specific for the dye used to label them (Fig. 3) .
A selection of software tools for image analysis is freely available to the research community: CellProfiler (http://www.cellprofiler. org/) and ImageJ (http://rsbweb.nih.gov/ij/) can be used to derive data from the original images in a number of different file formats. They both offer a variety of algorithms that can be used in different ways depending on the purpose of the analysis.
A script for identification and counting of cells and RCPs, 'Speckle Counting', is available at CellProfiler website (http:// www.cellprofiler.org/examples.shtml SBS_CNT). Briefly, grayscale images from single fluorescence channels are loaded. Cell nuclei and cytoplasms are defined with threshold algorithms. RCPs are identified and related to single cells. Finally, the total number of cells is counted, as well as the number of RCPs, which is now related to each individual cell. The data are exported as a .csv file, which can be used for further statistical analysis. For better visualization, z-stacks were combined as a maximum-intensity projection and brightness and contrast of all channels was adjusted. 5 ). Prepare the buffer before starting the experiment and store it in 1-ml aliquots at − 20 °C for ~1 year. T4 DNA ligation buffer, 10× Combine 100 mM Tris acetate (pH 7.5), 100 mM magnesium acetate and 500 mM potassium acetate. Prepare the buffer before starting the experiment and store it in 1-ml aliquots at − 20 °C for ~1 year. PBS buffer, 1×, pH 7.4 Mix 137 mM NaCl, 10 mM phosphate and 2.7 mM KCl. Prepare the buffer before starting the experiment and store it at RT for up to 6 months. Set the pH to 7.5. Prepare the buffer before starting the experiment and store it at RT for up to 6 months. Saline-sodium citrate buffer, pH 7, 20× (SSC) Combine 3 M sodium chloride and 300 mM trisodium citrate. Prepare the buffer before starting the experiment and store it at RT for up to 6 months. TBS buffer, 1× (tris-buffered saline), pH 7.6 Mix 50 mM Tris and 150 mM NaCl. Prepare the buffer before starting the experiment and store it at RT for up to 6 months. Hybridization mix, 2× Mix 4× SSC and 40% (vol/vol) formamide. Prepare the hybridization mix before starting the experiment and store it at RT protected from light. This reagent is stable for at least 6 months.
Washing buffer PBS-T Mix 1× DEPC-treated PBS (DEPC-
•
proceDure slide preparation • tIMInG variable; 6 h to several days 1| Seed or place cells on microscopy slides, coverslips or on any dish suited for later use in microscopy. The cells should either be incubated long enough to allow them to attach to the slide at ~60-90% confluence or seeded and incubated to meet the experimental requirements (e.g., when cells should be stimulated at a particular density for a certain amount of time).
Fixation
• tIMInG 40 min 2| Wash the slides once, for ~1 min, in a Coplin jar with ice-cold DEPC-PBS. ! cautIon DEPC is harmful as long as it is not inactivated. PFA is harmful. All contact with skin, eyes and clothes should be avoided.  crItIcal step All reagents and consumables should be RNase free or DEPC treated to ensure preservation of the mRNA.
3|
Fix the cells in freshly prepared 2% (wt/vol) PFA in DEPC-PBS in a Coplin jar for 30 min at RT. 7| Air-dry the slides in an upright position.  pause poInt Dry slides can be stored at − 20 °C for ~1 week. Longer storage may be possible; however, for the detection of PTMs, ensure that the storage does not affect detection efficiency.
8|
Attach Secure Seal chambers to the dry slides with each chamber sealing one sample.
9|
Rehydrate the cells by adding 1× PBS-T to the chambers.  crItIcal step All subsequent incubations are done in the Secure Seal chambers. Reaction volumes should be adjusted such that the reaction chambers are completely filled. Before washes or before adding new reagents, the chambers should be emptied by pipetting. For incubations exceeding 30 min, the Secure Seal chambers should be sealed with tape to prevent evaporation. Perform all incubations with the slides placed in a humidity chamber.  crItIcal step From now on, ′washing′ means removing the liquid from the Secure Seal chamber, refilling it with wash buffer and then flushing four times the volume of the Secure Seal chamber slowly through the chamber.
reverse transcription • tIMInG 3 h 10 min 10| Mix the reagents in a microtube as described below and then add them to the samples.  crItIcal step Apply the mix immediately after preparation to the sample, as extended storage on ice might impair the enzyme activity.
11|
Incubate the mixture for 3 h at 37 °C in a humidity chamber in a heat cabinet. Remember to seal the openings of the Secure Seals with self-adhesive PCR film to avoid evaporation.
12|
Wash the slides twice in PBS-T.
postfixation • tIMInG 40 min 13| Perform a second fixation to secure the cDNA molecules by incubating them in freshly prepared 2% (wt/vol) PFA in DEPC-PBS for 30 min at RT in a humidity chamber. ! cautIon PFA is harmful. All contact with skin, eyes and clothes should be avoided.  crItIcal step Apply the mix immediately after preparation to the sample, as extended storage on ice might impair the enzyme activity.
14|

16|
Incubate the mixture for 30 min at 37 °C to allow RNase H digestion and hybridization, and then for 45 min at 45 °C for ligation in a humidity chamber in a heat cabinet.
17|
Blocking
• tIMInG 1 h 30 min 18| Mix the reagents in a microtube as described below and then add them to the samples. Seal the Secure Seal openings with self-adhesive PCR film.  crItIcal step From this point, the slides must not dry. Drying of the slides will lead to unspecific staining.
19|
Incubate the slides for 90 min at 37 °C in a humidity chamber.
primary antibodies • tIMInG variable; 1 h to overnight 20| Mix the reagents in a microtube as described below and then add them to the samples. Seal the Secure Seal openings with self-adhesive PCR film. 24| Combine Mixes A and B and add the 50-µl A + B mix to the samples. Seal the Secure Seal openings with self-adhesive PCR film. Incubate for 1 h at 37 °C in a humidity chamber.
25|
Wash the samples once in 10 mM Tris-HCl (pH 7.5) with 0.1% (vol/vol) Tween-20 for 5 min at 37 °C in a humidity chamber in a heat cabinet.
26|
Wash the slides once in PBS-T.
Hybridization of circularization oligonucleotides • tIMInG 40 min 27|
Mix the reagents in a microtube as described below and then add them to the samples. Seal the Secure Seal openings with self-adhesive PCR film. 31| Ligate the samples for 30 min at 37 °C in a humidity chamber in a heat cabinet.
32|
Wash the slides once in PBS-T.  crItIcal step Apply the mix immediately after preparation to the sample, as extended storage on ice might impair the enzyme activity.
34|
Incubate for 90 min at 37 °C in a humidity chamber in a heat cabinet.
35|
Wash the slides once in PBS-T.  pause poInt After RCA, the slides can be stored in PBS-T at 4 °C overnight.
labeling • tIMInG 50 min 36| Mix the reagents in a microtube as described below and then add them to the samples. Seal the Secure Seal openings with self-adhesive PCR film.  crItIcal step The samples should be protected from light from this step and onward.
37|
Hybridize the detection oligonucleotides to the RCPs for 30 min at 37 °C in a humidity chamber in the dark in a heat cabinet. (Optional) If a counterstaining for special structures in the cells (e.g., actin or nuclei) is desired, it can be performed at this step before removal of the Secure Seals.
38|
Remove the labeling mix.
39|
Mark the positions of the Secure Seals with, e.g., a diamond pen.
40|
Remove the Secure Seals.
41|
Wash the cells twice in TBS for 10 min at RT.
42|
Mount the slides in Vectashield mounting medium (or an equivalent) and cover them with coverslips.
Image acquisition and analysis • tIMInG ~1 h 43| Acquire the results using an epifluorescence or confocal microscope.  crItIcal step Choose a confocal microscope if your sample is very thick or if the precise location of the RCPs is important for evaluation. For thin samples, e.g., cultured cells, epifluorescence images are usually sufficient.
? trouBlesHootInG
44|
Choose a suitable objective depending on the degree of detail needed for sample evaluation of the location of RCPs and the number of cells to be captured per image.  crItIcal step Consider how the samples are to be evaluated afterward and how many cells are needed for this evaluation. We recommend that images be acquired from several positions from each condition (two or three) in order to compensate for variations within each well. Usually ×20-×63 magnification is sufficient in terms of resolution and amount of cells per image.
45|
Set the exposure time for each channel to obtain clear signals but avoid saturation.  crItIcal step The number of channels to be acquired depends on the number of different in situ PLA and padlock targets, as well as on additional counterstainings applied. We recommend that the exposure time be chosen on the positive control sample or the sample in which the highest signal is expected.
46|
Acquire z-stack images of each position to capture RCPs in all focal planes. located throughout the cell (the image shows a maximum intensity projection, and therefore signals for the PDGFR also appear in the nucleus), ACTB mRNA is restricted closer to the nucleus. All RCPs should localize inside the cellular boundaries, as both in situ PLA signals and in situ mRNA signals stay attached to the molecule of origin. Occasional signals on the slide can occur, especially for in situ PLA signals, as the antibodies can 'stick' unspecifically to the surface and give rise to RCPs. However, the RCPs should be easily distinguishable from background autofluorescence. If the fluorescence signal is too high, it is probable that the slide has dried out during handling and that these signals are unspecific. The detection efficiency is slightly better in fresh-frozen tissue and cells than in FFPE tissue. This is observed as a lower signal density. In tissue sections, the RCA is given more time. As a consequence, the fluorescent signals can appear to be bigger than those seen in cells. . The RCPs coupled to the transcripts were visualized with a Cy3-labeled detection oligonucleotide, and the nuclei were stained with Hoechst. Scale bars, 20 µm. Typically, the detection efficiency is better in fresh-frozen cells and tissues than in FFPE tissues. This is seen as a lower signal density. The signals can also appear to be larger than those seen in cells, as the RCA is carried out for at least 5 h in tissues compared with 1 h for cells.
47|
